![]() |
|
|
|
Compare Shop Books - Help - About - Book Links - Book Coupons |
Anesthesiology Books Cardiology Books Dermatology Books Emergency Medicine Books Endocrinology Books Geriatrics Books Gynecology and Obstetrics Books Hematology Books Immunology Books Infectious Diseases Books Internal Medicine Books Nephrology Books Neurology Books Oncology Books Ophthalmology Books Orthopedics Books Otolaryngology Books Radiology Books Sports Medicine Books Urology Books |
|
Table of Contents:
Chair's introduction 1
The problem of the drug-resistant epilepsies 4
Drug resistance molecules: lessons from oncology 19
Drug resistance in epilepsy: the role of the blood-brain barrier 38
P glycoprotein and the mechanism of multidrug resistance 54
Drug resistance caused by multidrug resistance-associated proteins 69
Reversal of multidrug resistance: lessons from clinical oncology 83
Clinical development of P glycoprotein modulators in oncology 103
Gene expression profiling of epothilone A-resistant cells 119
Imaging of P glycoprotein function in vivo with PET 137
Animal models of drug-resistant epilepsy 149
Drug resistance in epilepsy: human epilepsy 167
Cellular mechanisms of pharmacoresistance in slices from epilepsy surgery 186
Functional polymorphisms of the human multidrug resistance (MDR1) gene: correlation with P glycoprotein expression and activity in vivo 207
OC144-093, a novel P glycoprotein inhibitor for the enhancement of anti-epileptic therapy 213
Final general discussion 231
Closing remarks 236
Index of contributors 237
Subject index 239
| Compare Shop Books - Help - About - Book Links - Book Coupons |
| Terms of Service and Privacy Statement |